Developments in the treatment of hemophilia B: focus on emerging gene therapy

Hemophilia B is a genetic disorder that is characterized by a deficiency of clotting factor IX (FIX) and excessive bleeding. Advanced understanding of the pathophysiology of the disease has led to the development of improved treatment strategies that aim to minimize the acute and long-term complicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cancio, Maria I, Reiss, Ulrike M, Nathwani, Amit C, Davidoff, Andrew M, Gray, John T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805181/
https://www.ncbi.nlm.nih.gov/pubmed/24159262
http://dx.doi.org/10.2147/TACG.S31928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805181/
https://www.ncbi.nlm.nih.gov/pubmed/24159262
http://dx.doi.org/10.2147/TACG.S31928

Ejemplares similares